These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33603536)

  • 1. Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and
    Hermawan A; Ikawati M; Jenie RI; Khumaira A; Putri H; Nurhayati IP; Angraini SM; Muflikhasari HA
    Saudi Pharm J; 2021 Jan; 29(1):12-26. PubMed ID: 33603536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key genes of hesperidin in inhibition of breast cancer stem cells by functional network analysis.
    Hermawan A; Khumaira A; Ikawati M; Putri H; Jenie RI; Angraini SM; Muflikhasari HA
    Comput Biol Chem; 2021 Feb; 90():107427. PubMed ID: 33360419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics and
    Hermawan A; Ikawati M; Khumaira A; Putri H; Jenie RI; Angraini SM; Muflikhasari HA
    Adv Pharm Bull; 2021 Feb; 11(2):351-360. PubMed ID: 33880358
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZGRF1 Is Associated with Poor Prognosis in Triple-Negative Breast Cancer and Promotes Cancer Stemness Based on Bioinformatics.
    Ge W; Jiang M; Zhang F; Ma Y; Wang H; Xu Y
    Onco Targets Ther; 2020; 13():2843-2854. PubMed ID: 32308418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
    Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
    Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.
    Jiang B; Zhu H; Tang L; Gao T; Zhou Y; Gong F; Tan Y; Xie L; Wu X; Li Y
    Anticancer Agents Med Chem; 2022; 22(9):1723-1734. PubMed ID: 33845750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and
    Hermawan A; Ikawati M; Putri DDP; Fatimah N; Prasetio HH
    Nutr Cancer; 2024; 76(7):638-655. PubMed ID: 38721626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells.
    Kim SL; Choi HS; Lee DS
    Cell Commun Signal; 2023 Nov; 21(1):315. PubMed ID: 37924094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of gene-phenotype connectivity associated with flavanone naringenin by functional network analysis.
    Fu S; Zhang Y; Shi J; Hao D; Zhang P
    PeerJ; 2019; 7():e6611. PubMed ID: 30918758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.
    Kim SH; Sehrawat A; Singh SV
    Cancer Prev Res (Phila); 2013 Aug; 6(8):782-90. PubMed ID: 23661606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
    Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S
    Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
    Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
    Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.
    Xu Z; Huang B; Liu J; Wu X; Luo N; Wang X; Zheng X; Pan X
    Toxicology; 2018 Dec; 410():231-246. PubMed ID: 30153467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
    Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
    Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
    Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
    Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroprotective mechanisms of naringenin: Inhibition of apoptosis through the PI3K/AKT pathway after hypoxic-ischemic brain damage.
    Li L; Lin Z; Yuan J; Li P; Wang Q; Cho N; Wang Y; Lin Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116941. PubMed ID: 37480970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells.
    Skolastika S; Hanif N; Ikawati M; Hermawan A
    Evid Based Complement Alternat Med; 2022; 2022():4172531. PubMed ID: 35845599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.
    Fu YZ; Yan YY; He M; Xiao QH; Yao WF; Zhao L; Wu HZ; Yu ZJ; Zhou MY; Lv MT; Zhang SS; Chen JJ; Wei MJ
    Oncol Rep; 2016 Feb; 35(2):912-22. PubMed ID: 26718029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.